$AVIR
Atea Pharmaceuticals Inc
PRICE
$8.17 ▼-0.122%
Extented Hours
VOLUME
783,741
DAY RANGE
7.555 - 8.2962
52 WEEK
5.31 - 46.91
Key Metrics
Market Cap
629.01 M
Beta
1.01
Avg. Volume
728.87 K
Shares Outstanding
83.26 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-09
Next Dividend Date
Company Information
Atea is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging its deep understanding of antiviral drug development, nucleoside biology, and medicinal chemistry, the Company has built a proprietary purine nucleotide prodrug platform to develop novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of severe viral diseases. Currently, the Company is focused on the development of orally available, potent, and selective nucleotide prodrugs for difficult-to-treat, life-threatening viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, dengue virus, hepatitis C virus (HCV) infection, and respiratory syncytial virus (RSV).
Website: ateapharma.com
HQ: ,
Related News